A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Clinical trial NCT05462106 · RECRUITING

Trial details

NCT number: NCT05462106
Sponsor: AC Immune SA
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyloid Plaque Beta-Amyloid DSAD Prodromal Alzheimer's Disease Alzheimer's Disease

Start date: 2022-06-21
Primary completion: 2029-04-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.